/Companies

Oncorus

Cambridge, US · Founded 2015 · Delaware corporation · 7 employees on LinkedIn · 7 known investors

Find your way into Oncorus

Sign up to see every warm intro you have to Oncorus

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncorus team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

CQChristophe Queva
Christophe QuevaExecutiveChristophe Queva has held R&D leadership roles at AstraZeneca, Amgen, and Gilead Sciences, where he directed translational science for an approved oncology therapy, and has served as President, CEO, or Chief Scientific Officer at biotech firms including Triptych Therapeutics, Egle Therapeutics, and iTeos. He brings over two decades of experience in oncology and immuno-oncology program development, regulatory strategy, and organizational building, with additional board experience at Bpifrance.
TA
Theodore AshburnNamed on SEC filing
AL
Alon LazarusNamed on SEC filing
CWCameron Wheeler
Cameron WheelerNamed on SEC filingPartner at Deerfield Management Company

Board

BMBriggs Morrison
Briggs MorrisonBoard directorEntrepreneur Partner at MPM BioImpact
MF
Mitchell FinerBoard directorManaging Partner at MPM Capital
LELuke Evnin
Luke EvninBoard directorAdvisor at MPM BioImpact

Investors · 7

Reported raises · per SEC filings

Form D private placements

$115.1M disclosed across 2 rounds · 2016–2019

▶$53.8MraisedDec 2019 · 30 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Theodore AshburnExecutive Officer, Director
  • Briggs MorrisonDirector
  • Mitchell FinerDirector
  • Cameron WheelerDirector
  • Mary Kay FentonDirector
  • Robert KirkmanDirector
  • Spencer NamDirector
  • Christophe QuevaExecutive Officer
  • John McCabeExecutive Officer
  • Luke EvninDirector
Offering amount
$89.6M
Amount sold
$53.8M
First sale
Aug 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$61.3MraisedSep 2018 · 17 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Briggs MorrisonDirector
  • Theodore AshburnExecutive Officer, Director
  • Mitchell FinerExecutive Officer, Director
  • Alon LazarusDirector
  • Cameron WheelerDirector
  • Luke EvninDirector
  • Christophe QuevaExecutive Officer
Offering amount
$61.4M
Amount sold
$61.3M
First sale
Mar 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

4 people who came through Oncorus went on to found or lead other companies.

Frequently asked questions

Who are Oncorus's investors?
Oncorus's investors include Astellas Venture Management LLC, Cowen Healthcare Investments, Deerfield Management Company, IMM Investment, K2 HealthVentures, MPM BioImpact, Sphera Funds Management.
How much funding has Oncorus raised?
Oncorus has disclosed $115.1M raised across 2 rounds.
Where is Oncorus headquartered?
Oncorus is headquartered in Cambridge, US.